Rapidly Progressive Homonymous Hemianopia in the Heidenhain Variant of Creutzfeldt-Jakob Disease

REFERENCES

• Lueck G, McIlwaine GG, Zeidler M. Creutzfeldt-Jakob disease and the eye. IL Ophthalmic and neuro-ophthalmic features. Eye 2000;14:291–301.
   Web of Science ®Google Scholar
• Heidenhain A. Klinische und anatomische Untersuchungen uber eine eigenartige organische Erkrankung des Zentralcervensystems im Praesenium. Z Ges Neurol Psychiatr 1929;118:49–114.
   Google Scholar
• Meyer A, Leigh D, Bagg CE. A rare presenile dementia associated with cortical blindness (Heidenhain’s syndrome). J Neurol Neurosurg Psychiatr 1954;17:129–133.
   PubMed Web of Science ®Google Scholar
• Jacobs DA, Lesser RL, Mourelatos Z, Galetta SL, Balcer LJ. The Heidenhain variant of Creutzfeldt-Jakob disease: clinical, pathologic, and neuroimaging findings. J Neuroophthalmol 2001;21:99–102.
   PubMed Web of Science ®Google Scholar
• Cooper SA, Murray KL, Heath CA, Will RG, Knight RS. Isolated visual symptoms at onset in sporadic Creutzfeldt-Jakob disease: the clinical phenotype of the “Heidenhain variant”. Br J Ophthalmol 2005;89:1341–1342.
   PubMed Web of Science ®Google Scholar
• Kropp S, Schulz-Schaeffer WJ, Finkenstaedt M, Riedemann C, Windl O, Steinhoff BJ, Zerr I, Kretzschmar HA, Poser S. The Heidenhain variant of Creutzfeldt-Jakob disease. Arch Neurol 1999;56:55–61.
   PubMedGoogle Scholar
• Purvin V, Bonnin J, Goodman J. Palinopsia as a presenting manifestation of Creutzfeldt-Jakob disease. J Clin Neuroophthalmol 1989;9:242–6; discussion 242.
   PubMedGoogle Scholar
• Yamanouchi H, Budka H, Vass K Sr. Unilateral Creutzfeldt-Jakob disease. Neurology 1986;36:1517–1520.
   PubMed Web of Science ®Google Scholar
• Brown P, Cathala F, Sadowsky D, Gajdusek DC. Creutzfeldt-Jakob disease in France: II. Clinical characteristics of 124 consecutive verified cases during the decade 1968–1977. Ann Neurol 1979;6:430–437.
   PubMed Web of Science ®Google Scholar
• Vargas ME, Kupersmith MJ, Savino PJ, Frohman LP, Warren FA. Homonymous field defect as the first manifestation of Creutzfeldt-Jakob disease. Am J Ophthalmol 1995;119:497–504.
   PubMed Web of Science ®Google Scholar
• Lesser RL, Albert DM, Bobowick AR, O’Brien FH. Creutzfeldt-Jakob disease and optic atrophy. Am J Ophthalmol 1979;87:317–321.
   Web of Science ®Google Scholar
• Foundas M, Donaldson MD, McAllister IL, Bridges LR. Vision loss due to coincident ocular and central causes in a patient with Heidenhain variant Creutzfeldt-Jakob disease. Age Ageing 2008;37:231–232.
   Google Scholar
• Sato Y, Chiba S, Miyagishi T. A case of the panencephalopathic type of Creutzfeldt-Jakob disease with retinal involvement. Hokkaido Igaku Zasshi 1992;67:703–711.
   Google Scholar
• Kitagawa Y, Gotoh F, Koto A, Ebihara S, Okayasu H, Ishii T, Matsuyama H. Creutzfeldt-Jakob disease: a case with extensive white matter degeneration and optic atrophy. J Neurol 1983;229:97–101.
   Google Scholar
• Masters CL, Richardson EP Jr. Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change. Brain 1978;101:333–344.
   PubMed Web of Science ®Google Scholar
• Brown DR, Schmidt B, Kretzschmar HA. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature 1996;380:345–347.
   PubMed Web of Science ®Google Scholar
• Finkenstaedt M, Szudra A, Zerr I, Poser S, Hise JH, Stoebner JM, Weber T. MR imaging of Creutzfeldt-Jakob disease. Radiology 1996;199:793–798.
   PubMed Web of Science ®Google Scholar
• Prasad S, Lee EB, Woo JH. MRI and positron emission tomography findings in Heidenhain variant Creutzfeldt-Jakob disease. J Neuroophthalmol 2010;30:260–262.
   Web of Science ®Google Scholar
• Clarençon F, Gutman F, Giannesini C, Pénicaud A, Galanaud D, Kerrou K, Marro B, Talbot JN. MRI and FDG PET/CT findings in a case of probable Heidenhain variant Creutzfeldt-Jakob disease. J Neuroradiol 2008;35:240–243.
   PubMed Web of Science ®Google Scholar
• Meissner B, Kohler K, Kortner K, Bartl M, Jastrow U, Mollenhauer B, Schröter A, Finkenstaedt M, Windl O, Poser S, Kretzschmar HA, Zerr I. Sporadic Creutzfeldt-Jakob disease magnetic resonance imaging and clinical findings. Neurology 2004;63:450–456.
   Web of Science ®Google Scholar
• Satoh J, Kurohara K, Yukitake M, Kuroda Y. The 14-3-3 protein detectable in the cerebrospinal fluid of patients with prion-unrelated neurological diseases is expressed constitutively in neurons and glial cells in culture. Eur Neurol 1999;41:216–225.
   PubMed Web of Science ®Google Scholar
• Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996;335:924–930.
   PubMed Web of Science ®Google Scholar
• Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro Cuesta J, Knight RS, Bernheimer H, Cardone F, Delasnerie-Lauprêtre N, Cuadrado Corrales N, Ladogana A, Bodemer M, Fletcher A, Awan T, Ruiz Bremón A, Budka H, Laplanche JL, Will RG, Poser S. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Arch Neurol 1996;53:913–920.
   Google Scholar
• Lemstra AW, van Meegen MT, Vreyling JP, Meijerink PH, Jansen GH, Bulk S, Baas F, van Gool WA. 14-3-3 testing in diagnosing Creutzfeldt-Jakob disease. Neurology 2000;55:514–516.
   PubMed Web of Science ®Google Scholar
• Castellani RJ, Colucci M, Xie Z, Zou W, Li C, Parchi P, Capellari S, Pastore M, Rahbar MH, Chen SG, Gambetti P. Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Neurology 2004;63:436–442.
   PubMed Web of Science ®Google Scholar
• Lemstra AW, van Meegen MT, Vreyling JP, Meijerink PH, Jansen GH, Bulk S, Baas F, van Gool WA. 14-3-3 testing in diagnosing Creutzfeldt-Jakob disease: a prospective study in 112 patients. Neurology 2000;55:514–516.
   PubMed Web of Science ®Google Scholar
• Sáiz A, Marín C, Tolosa E, Graus F. Diagnostic usefulness of the determination of protein 14-3-3 in cerebrospinal fluid in Creutzfeld-Jakob disease. Neurologia 1998;13:324–328.
   Google Scholar
• Geschwind MD, Martindale J, Miller D, DeArmond SJ, Uyehara-Lock J, Gaskin D, Kramer JH, Barbaro NM, Miller BL. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol 2003;60:813–816.
   PubMedGoogle Scholar